- Report
- May 2024
- 420 Pages
Global
From €2673EUR$3,000USD£2,319GBP
- Report
- February 2024
- 50 Pages
Global
From €2139EUR$2,400USD£1,855GBP
- Report
- October 2023
- 420 Pages
Global
From €2584EUR$2,900USD£2,242GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2673EUR$3,000USD£2,319GBP
- Report
- February 2022
- 360 Pages
United States
From €3208EUR$3,600USD£2,783GBP
- Report
- October 2021
- 78 Pages
Global
From €713EUR$800USD£618GBP
- Report
- December 2021
- 353 Pages
Global
From €4901EUR$5,500USD£4,252GBP
- Report
- January 2024
- 140 Pages
Global
From €2941EUR$3,300USD£2,551GBP
- Report
- October 2022
- 510 Pages
China
From €2139EUR$2,400USD£1,855GBP
- Report
- October 2019
Global
From €2495EUR$2,800USD£2,165GBP
- Report
- October 2023
- 85 Pages
United States
From €4322EUR$4,850USD£3,749GBP
- Report
- September 2023
Global
From €4411EUR$4,950USD£3,827GBP
- Report
- September 2023
- 324 Pages
Global
From €4411EUR$4,950USD£3,827GBP
- Report
- January 2023
- 356 Pages
Global
From €4411EUR$4,950USD£3,827GBP
- Report
- March 2023
Germany
From €1337EUR$1,500USD£1,160GBP
- Report
- November 2022
- 197 Pages
United States
From €3342EUR$3,750USD£2,899GBP
- Report
- January 2022
- 292 Pages
Global
From €3342EUR$3,750USD£2,899GBP
- Report
- May 2023
United States
From €1337EUR$1,500USD£1,160GBP
- Report
- March 2024
- 181 Pages
Global
From €2183EUR$2,450USD£1,894GBP
- Report
- June 2023
- 361 Pages
Global
From €2451EUR$2,750USD£2,126GBP
€4901EUR$5,500USD£4,252GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more